CANGET BIOTEKPHARMA
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents. It provides low toxic and cancer-targeting anticancer agents for patients, enabling medical practitioners to improve patient survival time and survival rate through controlling cancer cell drug resistance and tumor relapse. The company focuses on the development of novel, cancer-targeting anticancer agents that exhibit low toxicity to normal tissue and high efficacy to cancer. Canget BioTekpharma was established in 2012 and is headquartered in Buffalo, New York.
CANGET BIOTEKPHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2012-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.canget-biotek.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
25 K USD
Technology used in webpage:
Apache 1and1 1and1 Email Solutions
Similar Organizations
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.canget-biotek.com
- Host name: 74-208-236-149.elastic-ssl.ui-r.com
- IP address: 74.208.236.149
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Canget BioTekpharma"
Canget BioTekpharma LLC
Canget BioTekpharma, LLC (Canget) is a biotech and biopharma company, and was spun off in 2012 from Roswell Park Cancer Institute (RPCI, Buffalo, New York).Canget focuses on โฆSee details»
Canget BioTekpharma - Crunchbase Company Profile โฆ
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents. It provides low toxic and cancer โฆSee details»
Canget BioTekpharma, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Canget BioTekpharma, LLC of Buffalo, NY. Get the latest business insights from Dun & Bradstreet. โฆSee details»
Canget BioTekpharma - Org Chart, Teams, Culture & Jobs - The Org
Canget BioTekpharma, LLC (Canget) is a biotech and biopharma company, and was spun off in 2012 from Roswell Park Cancer Institute (RPCI, Buffalo, New York). Canget focuses on the โฆSee details»
Canget BioTekpharma LLC - Drug pipelines, Patents, Clinical
Explore Canget BioTekpharma LLC with its drug pipeline, therapeutic area, technology platform, 8 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, Hemic and โฆSee details»
CANGET BIOTEKPHARMA, LLC - VentureRadar
Canget BioTekpharma LLC is a biotechnology research company and anti-cancer drug developer. It identified a water-insoluble novel drug that can improve outcomes for advanced late-stage โฆSee details»
Canget BioTekpharma - Overview, News & Similar companies
Canget BioTekpharma is a biotech and biopharma company, which was spun off from Roswell Park Cancer Institute (RPCI, Buffalo, New York) and focuses on development of novel, cancer โฆSee details»
Canget BioTekpharma 2025 Company Profile: โฆ
Canget BioTekpharma General Information Description. Operators of a biotechnology company intended to develop novel, cancer-targeting anticancer agents. The company provides highly effective, low-toxicity, and cancer โฆSee details»
Canget BioTekpharma | Buffalo, NY, USA Startup - gust.com
Cangetโs technology has taken 7 years and $3M funds from federal, public and private foundations to develop its current IP portfolio. Canget was officially formed in New York State โฆSee details»
Canget Biotekpharma - Products, Competitors, Financials, โฆ
Canget Biotekpharma is a biotech and biopharma company that specializes in the development of novel cancer-targeting anticancer agents. Their main focus is on creating treatments that are โฆSee details»
CANGET BIOTEKPHARMA, LLC Overview - SignalHire
Organization Website: canget-biotek.com : Headquarters Location: BUFFALO, New York, US BUFFALO, New York, US : CANGET BIOTEKPHARMA,... Employees Size 1-10 employees: โฆSee details»
Canget BioTekpharma LLC
Canget BioTekpharma, founded by Dr. Fengzhi Li, is a biotech and biopharma company spun off from Roswell Park Cancer Institute (RPCI, Buffalo, New York) and focuses on development of โฆSee details»
Canget BioTekpharma - Funding, Financials, Valuation & Investors
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents. New. Resources. Advanced Search. Start Free Trial . Talk With โฆSee details»
Canget BioTekpharma's Leadership Team Team - The Org
Other teams at Canget BioTekpharma. View all +5. Board of Directors. 8 members. CEO and Executive Team. 3 members. Discover similar companies. ONI. Series B · San Diego, United โฆSee details»
Canget BioTekpharma: A One Pager for Selling to this Stealth
Dec 8, 2020 Canget and Roswell Park have found that the chemical core structure of FL118 is a great novel drug-generating platform for producing a series of FL118 analogues with โฆSee details»
Canget BioTekpharma LLC
Geoffrey White, PhD - Dr. White is the Chief Executive Officer (CEO) of Canget. Dr. White received his PhD from the University of Virginia in Charlottesville in 1985. He has worked in โฆSee details»
Canget BioTekpharma - Contacts, Employees, Board Members
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents. New. ... Experience the new Crunchbase, powered by AI . โฆSee details»
Canget BioTekpharma LLC
Canget BioTekpharma, founded by Dr. Fengzhi Li, is a biotech and biopharma company spun off from Roswell Park Cancer Institute (RPCI, Buffalo, New York) and focuses on development of โฆSee details»
John J. Seman - Acting CEO at Canget BioTekpharma - The Org
Canget BioTekpharma, LLC (Canget) is a biotech and biopharma company, and was spun off in 2012 from Roswell Park Cancer Institute (RPCI, Buffalo, New York). Canget focuses on the โฆSee details»
Canget BioTekpharma LLC
Canget BioTekpharma (Canget) has been selected as an Emerging Company to give an oral presentation on the BioNJ 14th Bio-partnering Conference, May 14, 2024 (BioNJ โฆSee details»